(2R,3S,5R)-2-(Hydroxymethyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl 4-oxopentanoate

Catalog No. :
ACLHKQ423
CAS No. :
93134-41-9
Molecular Formula :
C19H25N5O7
Molecular Weight :
435.44

IUPAC Name:(2R,3S,5R)-2-(hydroxymethyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl 4-oxopentanoate

(2R,3S,5R)-2-(Hydroxymethyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl 4-oxopentanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3S,5R)-2-(Hydroxymethyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl 4-oxopentanoate
IUPAC Name(2R,3S,5R)-2-(hydroxymethyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl 4-oxopentanoate
MDL No.MFCD15145294
Molecular FormulaC19H25N5O7
Molecular Weight435.44
SMILESOC[C@@H]1[C@H](C[C@H](N2C=NC3=C2N=C(NC(C(C)C)=O)NC3=O)O1)OC(CCC(C)=O)=O
InChI KeyPSVAPVNSJMJAJV-YNEHKIRRSA-N
Synonym2'-Deoxy-N2-isobutyryl-3'-O-levulinoylguanosine;Guanosine, 2'-deoxy-N-(2-methyl-1-oxopropyl)-, 3'-(4-oxopentanoate);3'-O-Levulinoyl-N-benzoyl-2'-deoxyguanosine
CAS No.93134-41-9

Synthetic Route by SureRoute

1. ACLHKQ423 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLHKQ423 route product structure diagram
    ACLHKQ42393134-41-9
Inquiry

2. ACLHKQ423 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLBZV746 route compound structure diagram
    ACLBZV74668892-42-2 In Stock
  4. Then
  5. ACLHKQ423 route product structure diagram
    ACLHKQ42393134-41-9
Inquiry

Comments (0)